Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies
[Background and purpose] The delivery of therapeutics to the central nervous system (CNS) remains a major challenge due to the restrictive nature of the blood-brain barrier (BBB), a key evolutionary feature that preserves brain homeostasis. This review seeks to synthesize current knowledge on BBB co...
| Autores: | , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/419000 |
| Acesso em linha: | http://hdl.handle.net/10261/419000 https://api.elsevier.com/content/abstract/scopus_id/105026172164 |
| Access Level: | acceso abierto |
| Palavra-chave: | Brain delivery Central nervous system Lipid nanoparticles Targeted therapy |
| Resumo: | [Background and purpose] The delivery of therapeutics to the central nervous system (CNS) remains a major challenge due to the restrictive nature of the blood-brain barrier (BBB), a key evolutionary feature that preserves brain homeostasis. This review seeks to synthesize current knowledge on BBB composition, physiology, and transport mechanisms, and critically analyses drug delivery strategies aimed at overcoming this barrier and enabling effective CNS therapies. |
|---|